|
⚲
|
| Keyboard |
| Kathleen Laporte | |
|---|---|
| Firm | |
| Address | 201 Haskins Way, Suite 230 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| CERO Therapeutics Holdings Inc | 021-545301 | Director | 5.0 M of 8.0 M |
||
| CERO Therapeutics Holdings Inc | 021-525940 | Director | 1.2 M of 1.2 M |
||
| Bolt Biotherapeutics Inc | 021-402021 | Director | 15.0 M of 15.0 M |
||
| Bolt Biotherapeutics Inc | 021-387686 | Director | 93.5 M of 93.5 M |
||
| D2G Oncology Inc | 021-361569 | Director | 8.7 M of 8.7 M |
||
| Affymax Inc | 021-55801 | Director | 42.0 M of 42.0 M |
||